These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1830915

  • 21. Liver pathology following hepatic arterial infusion chemotherapy. Hepatic toxicity with FUDR.
    Doria MI, Shepard KV, Levin B, Riddell RH.
    Cancer; 1986 Aug 15; 58(4):855-61. PubMed ID: 2941140
    [Abstract] [Full Text] [Related]

  • 22. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump.
    Weiss GR, Garnick MB, Osteen RT, Steele GD, Wilson RE, Schade D, Kaplan WD, Boxt LM, Kandarpa K, Mayer RJ.
    J Clin Oncol; 1983 May 15; 1(5):337-44. PubMed ID: 6199474
    [Abstract] [Full Text] [Related]

  • 23. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G.
    Hepatogastroenterology; 2001 May 15; 48(41):1302-7. PubMed ID: 11677951
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
    Patt YZ, Mavligit GM, Chuang VP, Wallace S, Johnston S, Benjamin RS, Valdivieso M, Hersh EM.
    Cancer; 1980 Jul 15; 46(2):261-5. PubMed ID: 6446376
    [Abstract] [Full Text] [Related]

  • 26. Regional chemotherapy of colorectal cancer metastatic to the liver.
    Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E.
    Cancer; 1984 Mar 15; 53(6):1336-43. PubMed ID: 6229326
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
    Faynsod M, Wagman LD, Longmate J, Carroll M, Leong LA.
    J Clin Oncol; 2005 Aug 01; 23(22):4876-80. PubMed ID: 16009960
    [Abstract] [Full Text] [Related]

  • 31. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.
    Ann Surg Oncol; 2011 Jul 01; 18(7):1924-31. PubMed ID: 21207165
    [Abstract] [Full Text] [Related]

  • 32. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ, Boddie AW, Charnsangavej C, Ajani JA, Wallace S, Soski M, Claghorn L, Mavligit GM.
    J Clin Oncol; 1986 Sep 01; 4(9):1356-64. PubMed ID: 2943876
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.
    Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM.
    Ann Surg; 1987 Dec 01; 206(6):685-93. PubMed ID: 2961314
    [Abstract] [Full Text] [Related]

  • 35. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N, Jarnagin W, Gonen M, Stockman J, Blumgart L, Sperber D, Hummer A, Fong Y.
    J Clin Oncol; 2003 Sep 01; 21(17):3303-9. PubMed ID: 12947066
    [Abstract] [Full Text] [Related]

  • 36. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
    O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE.
    J Clin Oncol; 1998 Jul 01; 16(7):2528-33. PubMed ID: 9667274
    [Abstract] [Full Text] [Related]

  • 37. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
    Kemeny N, Conti JA, Cohen A, Campana P, Huang Y, Shi WJ, Botet J, Pulliam S, Bertino JR.
    J Clin Oncol; 1994 Nov 01; 12(11):2288-95. PubMed ID: 7964942
    [Abstract] [Full Text] [Related]

  • 38. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F, Kornmann M, Beger HG.
    Eur J Surg Oncol; 1999 Aug 01; 25(4):381-8. PubMed ID: 10419708
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
    Gerard A, Pector JC, Bleiberg H.
    Gan To Kagaku Ryoho; 1988 Aug 01; 15(8 Pt 2):2351-4. PubMed ID: 3137873
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.